Tapewire

Nasdaq · USD

CHRN

ChronoScale Holdings Corp

Export transactions ↓
Tapewire entity
4331
SEC CIK
0001549084
Parsed reports
210

Last 12 months

Inside the activity.

12 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202502
Jan 202601
Feb 2026100
Mar 202620
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 15, 2022 Filed Jun 17, 2022 20:22 UTC
SHERMAN STEVENDirector · CEO & Chairman
SaleCommon Stock 6,911 $1.90 $13,118.46
Disclosure

SEC source: 0001549084-22-000035 · wf-form4_165551172719268.xml · nonDerivative · entry 2

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 648,762

F3 · shares: Represents shares sold by the Reporting Person on June 15, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the Reporting Person's RSUs.

F4 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.88 to $1.94, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Read SEC document
June 09, 2022 Filed Jun 18, 2022 00:36 UTC GrantCommon Stock 51,721 $0.00 $0.00
Disclosure

SEC source: 0001666769-22-000004 · wf-form4_165551258388396.xml · nonDerivative · entry 2

Cloyd Mary Ann · CIK 0001666769 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,896

F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F3 · date: This award of RSUs was granted effective June 9, 2022, the date of the Company's 2022 annual meeting of stockholders (the "Second Grant Date"), pursuant to the Annual RSU Grant Program. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Second Grant Date.

Read SEC document
June 09, 2022 Filed Jun 17, 2022 20:30 UTC GrantCommon Stock 51,721 $0.00 $0.00
Disclosure

SEC source: 0001316499-22-000004 · wf-form4_165551219037780.xml · nonDerivative · entry 2

Stern Stanley · CIK 0001316499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,221

F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F3 · date: This award of RSUs was granted effective June 9, 2022, the date of the Company's 2022 annual meeting of stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

Read SEC document
June 09, 2022 Filed Jun 18, 2022 00:34 UTC
Li KechengDirector
GrantCommon Stock 51,721 $0.00 $0.00
Disclosure

SEC source: 0001735083-22-000004 · wf-form4_165551243039722.xml · nonDerivative · entry 2

Li Kecheng · CIK 0001735083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,129

F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F3 · date: This award of RSUs was granted effective June 9, 2022, the date of the Company's 2022 annual meeting of stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

Read SEC document
June 09, 2022 Filed Jun 18, 2022 00:18 UTC GrantCommon Stock 51,721 $0.00 $0.00
Disclosure

SEC source: 0001838009-22-000003 · wf-form4_165551150324187.xml · nonDerivative · entry 2

Wallen Rhonda A. · CIK 0001838009 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,896

F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F3 · date: This award of RSUs was granted effective June 9, 2022, the date of the Company's 2022 annual meeting of stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

Read SEC document
June 09, 2022 Filed Jul 18, 2022 22:37 UTC GrantCommon Stock 51,721 $0.00 $0.00
Disclosure

SEC source: 0001714701-22-000004 · wf-form4_165818386173286.xml · nonDerivative · entry 1

Lathan Corinna · CIK 0001714701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,865

F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · date: This award of RSUs was granted effective June 9, 2022, the date of the Company's 2022 annual meeting of stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

Read SEC document
May 25, 2022 Filed May 26, 2022 20:33 UTC
Davis Scott G.President & COO
GrantCommon Stock 300,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-032210 · doc4.xml · nonDerivative · entry 1

Davis Scott G. · CIK 0001908860 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373,815

F1 · security: Represents restricted stock units ("RSUs").

F2 · date: The RSU grant was approved by the Compensation Committee of the Board of Directors on May 25, 2022.

F3 · shares: 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on January 21st of each year beginning in 2023.

Read SEC document
May 24, 2022 Filed May 26, 2022 20:32 UTC
SHERMAN STEVENDirector · CEO & Chairman
SaleCommon Stock 6,597 $1.76 $11,604.78
Disclosure

SEC source: 0001549084-22-000027 · wf-form4_165361154083193.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 637,408

F1 · shares: Represents shares sold by the Reporting Person on May 24, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the fourth installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022

F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.75 to $1.77, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Read SEC document
May 21, 2022 Filed May 24, 2022 19:07 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionRestricted Stock Units · Derivative 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000025 · wf-form4_165343361267752.xml · derivative · entry 2

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,794

Underlying: Common Stock · 15,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").

F2 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The fourth installment of RSUs vested on May 21, 2022 and were delivered to the Reporting Person upon settlement.

F2 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The fourth installment of RSUs vested on May 21, 2022 and were delivered to the Reporting Person upon settlement.

Read SEC document
May 21, 2022 Filed May 24, 2022 19:07 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionCommon Stock 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000025 · wf-form4_165343361267752.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 644,005

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 28, 2022 Filed May 2, 2022 17:28 UTC
SHERMAN STEVENDirector · CEO & Chairman
SaleCommon Stock 6,862 $2.41 $16,520.95
Disclosure

SEC source: 0001209191-22-026448 · doc4.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 628,406

F1 · shares: Represents shares sold by the Reporting Person on April 28, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the third installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022.

F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.38 to $2.43, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Read SEC document
April 21, 2022 Filed Apr 25, 2022 16:47 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionRestricted Stock Units · Derivative 15,599 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-025531 · doc4.xml · derivative · entry 2

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,393

Underlying: Common Stock · 15,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").

F2 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The third installment of RSUs vested on April 21, 2022 and were delivered to the Reporting Person upon settlement.

F2 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The third installment of RSUs vested on April 21, 2022 and were delivered to the Reporting Person upon settlement.

Read SEC document
April 21, 2022 Filed Apr 25, 2022 16:47 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionCommon Stock 15,599 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-025531 · doc4.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 635,268

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 20, 2022 Filed Apr 26, 2022 21:13 UTC
Davis Scott G.President & COO
SaleCommon Stock 4,043 $2.62 $10,582.96
Disclosure

SEC source: 0001209191-22-025648 · doc4.xml · nonDerivative · entry 1

Davis Scott G. · CIK 0001908860 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,815

F1 · shares: Represents shares sold by the Reporting Person on April 20, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards originally reported by the Reporting Person in a Form 4 filed with the Commission on February 22, 2022.

F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.61 to $2.63, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Read SEC document
April 07, 2022 Filed Apr 11, 2022 18:10 UTC
Jones Jason CVP of Product Development
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-024037 · doc4.xml · nonDerivative · entry 1

Jones Jason C · CIK 0001775619 · VP of Product Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,637

F1 · security: Represents restricted stock units ("RSUs").

F2 · date: The grant of RSUs was approved by the Compensation Committee of the Board of Directors on April 7, 2022.

F3 · shares: 1/3 of the total number of shares of Common Stock subject to the RSUs shall vest on August 30th of each year beginning 2022.

Read SEC document
March 24, 2022 Filed Mar 25, 2022 20:53 UTC
SHERMAN STEVENDirector · CEO & Chairman
SaleCommon Stock 6,389 $2.94 $18,783.66
Disclosure

SEC source: 0001209191-22-021200 · doc4.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 619,669

F1 · shares: Represents shares sold by the Reporting Person on March 24, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the second installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022.

F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.91 to $2.9767, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Read SEC document
March 22, 2022 Filed Mar 28, 2022 16:44 UTC
Jones Jason CVP of Product Development
SaleCommon Stock 3,265 $2.82 $9,206.32
Disclosure

SEC source: 0001209191-22-021328 · doc4.xml · nonDerivative · entry 1

Jones Jason C · CIK 0001775619 · VP of Product Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,637

F1 · shares: Represents shares sold by the Reporting Person on March 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards reported by the Reporting Person in Form 4s filed with the Commission on February 22, 2022 and March 5, 2021.

F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.88 to $2.81, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Read SEC document
March 22, 2022 Filed Mar 28, 2022 20:52 UTC
GLENN JOHNChief Financial Officer
SaleCommon Stock 3,462 $2.82 $9,761.80
Disclosure

SEC source: 0001209191-22-021330 · doc4.xml · nonDerivative · entry 1

GLENN JOHN · CIK 0001253497 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,130

F1 · shares: Represents shares sold by the Reporting Person on March 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards reported by the Reporting Person in Form 4s filed with the Commission on February 22, 2022 and March 5, 2021.

F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.88 to $2.81, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Read SEC document
March 21, 2022 Filed Mar 22, 2022 16:55 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionRestricted Stock Units · Derivative 15,599 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-020558 · doc4.xml · derivative · entry 2

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,992

Underlying: Common Stock · 15,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").

F2 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested and settled as of January 21, 2023. The second installment of RSUs vested and were delivered to the Reporting Person on March 21, 2022.

F2 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested and settled as of January 21, 2023. The second installment of RSUs vested and were delivered to the Reporting Person on March 21, 2022.

Read SEC document
March 21, 2022 Filed Mar 22, 2022 16:55 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionCommon Stock 15,599 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-020558 · doc4.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 626,058

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2022 Filed Mar 17, 2022 17:19 UTC
SHERMAN STEVENDirector · CEO & Chairman
SaleCommon Stock 5,965 $2.60 $15,508.40
Disclosure

SEC source: 0001209191-22-019690 · doc4.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 610,459

F1 · shares: Represents shares sold by the Reporting Person on March 15, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of a restricted stock unit award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022.

F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.5980 to $2.60, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request.

Read SEC document
March 08, 2022 Filed Mar 10, 2022 17:07 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionRestricted Stock · Derivative 15,599 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-017980 · doc4.xml · derivative · entry 3

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,591

Underlying: Common Stock · 15,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Shares represent restricted stock units ("RSUs") granted in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date"). The Issuer's Compensation Committee formally authorized the grant of such RSUs and the related RSU Agreement on March 8, 2022.

F3 · derivative.exercise_date: The first installment of the RSUs vested on February 21, 2022 and were delivered to the Reporting Person immediately in connection with the execution of the RSU Agreement.

F3 · derivative.expiration_date: The first installment of the RSUs vested on February 21, 2022 and were delivered to the Reporting Person immediately in connection with the execution of the RSU Agreement.

Read SEC document
March 08, 2022 Filed Mar 10, 2022 17:07 UTC
SHERMAN STEVENDirector · CEO & Chairman
GrantRestricted Stock Units · Derivative 187,190 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-017980 · doc4.xml · derivative · entry 2

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,190

Underlying: Common Stock · 187,190 shares

Expires not disclosed

F1 · derivative.exercise_price: Shares represent restricted stock units ("RSUs") granted in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date"). The Issuer's Compensation Committee formally authorized the grant of such RSUs and the related RSU Agreement on March 8, 2022.

F2 · derivative.exercise_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested on January 21, 2023.

F2 · derivative.expiration_date: The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested on January 21, 2023.

Read SEC document
March 08, 2022 Filed Mar 10, 2022 17:07 UTC
SHERMAN STEVENDirector · CEO & Chairman
Exercise / conversionCommon Stock 15,599 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-017980 · doc4.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 616,424

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 08, 2022 Filed May 17, 2023 19:46 UTC Amendment
SHERMAN STEVENExecutive Chair
Exercise / conversionRestricted Stock Units · Derivative 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000033 · wk-form4a_1684367209.xml · derivative · entry 2

SHERMAN STEVEN · CIK 0001201619 · Executive Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,591

Underlying: Common Stock · 15,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Shares represent restricted stock units ("RSUs") granted in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date"). The Issuer's Compensation Committee formally authorized the grant of such RSUs and the related RSU Agreement on March 8, 2022.

F3 · derivative.exercise_date: The first installment of the RSUs vested on February 21, 2022 and were delivered to the Reporting Person immediately in connection with the execution of the RSU Agreement.

F3 · derivative.expiration_date: The first installment of the RSUs vested on February 21, 2022 and were delivered to the Reporting Person immediately in connection with the execution of the RSU Agreement.

Read SEC document
March 08, 2022 Filed May 17, 2023 19:46 UTC Amendment
SHERMAN STEVENExecutive Chair
Exercise / conversionCommon Stock 15,599 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000033 · wk-form4a_1684367209.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Executive Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,564

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: On March 10, 2022, the Reporting Person filed a Form 4 that did not reflect the decrease in the Reporting Person's holdings caused by the Issuer's 1-for-15 reverse stock split effected on March 24, 2020. This Amendment corrects such inaccuracies.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 19:27 UTC
Jones Jason CVP of Product Development
GrantCommon Stock 13,760 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-011955 · doc4.xml · nonDerivative · entry 1

Jones Jason C · CIK 0001775619 · VP of Product Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,902

F1 · shares: Shares acquired pursuant to a restricted stock units award granted on March 3, 2021 that had both performance-based and time-based vesting conditions. The performance-based vesting conditions have been satisfied, and now the award is subject only to time-based vesting conditions. The award vests in three equal annual installments beginning on March 3, 2022.

Read SEC document
February 17, 2022 Filed Feb 23, 2022 00:23 UTC
GLENN JOHNChief Financial Officer
GrantCommon Stock 14,596 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-011950 · doc4.xml · nonDerivative · entry 1

GLENN JOHN · CIK 0001253497 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,592

F1 · shares: Shares acquired pursuant to a restricted stock units award granted on March 3, 2021 that had both performance-based and time-based vesting conditions. The performance-based vesting conditions have been satisfied, and now the award is subject only to time-based vesting conditions. The award vests in three equal annual installments beginning on March 3, 2022.

Read SEC document
February 17, 2022 Filed Feb 23, 2022 00:36 UTC
Davis Scott G.President & COO
GrantCommon Stock 41,158 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-011959 · doc4.xml · nonDerivative · entry 1

Davis Scott G. · CIK 0001908860 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,858

F1 · shares: Shares acquired pursuant to a restricted stock units award granted on April 8, 2021 that had both performance-based and time-based vesting conditions. The performance-based vesting conditions have been satisfied, and now the award is subject only to time-based vesting conditions. The award vests in three equal annual installments beginning on April 8, 2022.

Read SEC document
February 17, 2022 Filed Feb 23, 2022 00:33 UTC
Shaw William RChief Commercial Officer
GrantCommon Stock 17,943 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-011958 · doc4.xml · nonDerivative · entry 1

Shaw William R · CIK 0001776374 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,943

F1 · shares: Shares acquired pursuant to a restricted stock units award granted on March 3, 2021 that had both performance-based and time-based vesting conditions. The performance-based vesting conditions have been satisfied, and now the award is subject only to time-based vesting conditions. The award vests in three equal annual installments beginning on March 3, 2022.

Read SEC document
February 17, 2022 Filed Jun 15, 2023 21:59 UTC
Jones Jason CChief Operating Officer
GrantCommon Stock 3,346 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000045 · wk-form4_1686880789.xml · nonDerivative · entry 4

Jones Jason C · CIK 0001775619 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By 401K

Disclosed balance after: 4,491

Read SEC document
February 17, 2022 Filed Apr 4, 2024 21:21 UTC Amendment
Jones Jason CChief Operating Officer
GrantCommon Stock 3,446 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-011125 · rdgdoc.xml · nonDerivative · entry 1

Jones Jason C · CIK 0001775619 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By 401(k)

Disclosed balance after: 4,591

F1 · shares: On June 15, 2023, the Reporting Person filed a Form 4 that stated the incorrect number of shares of common stock acquired in connection with the Issuer's 401(k) plan matching contribution which occurred on 2/17/2022. This amendment corrects such inaccuracy and the related total number of securities indirectly owned at that date and subsequently.

F1 · balance_after: On June 15, 2023, the Reporting Person filed a Form 4 that stated the incorrect number of shares of common stock acquired in connection with the Issuer's 401(k) plan matching contribution which occurred on 2/17/2022. This amendment corrects such inaccuracy and the related total number of securities indirectly owned at that date and subsequently.

Read SEC document
December 25, 2021 Filed Dec 28, 2021 22:21 UTC GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-013595 · form4.xml · nonDerivative · entry 1

Lathan Corinna · CIK 0001714701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,144

F1 · price: The grant consists of Restricted Stock Units that will fully vest and settle at the earlier of (i) the date of the next annual meeting of stockholders or (ii) December 25, 2022.

F2 · balance_after: This includes 144 shares directly held in joint ownership with reporting person's spouse.

Read SEC document
August 31, 2021 Filed Sep 2, 2021 20:29 UTC
Peurach JackDirector · President & CEO
GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-054442 · doc4.xml · nonDerivative · entry 1

Peurach Jack · CIK 0001640206 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,142

F1 · security: Represents restricted stock units ("RTUs").

F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on August 31, 2021.

F3 · shares: 1/3 of the total number of shares of Common Stock subject to the RSUs shall vest on August 31st of each year beginning 2022.

Read SEC document
August 03, 2021 Filed Aug 4, 2021 20:41 UTC
Jones Jason CVP of Product Development
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-049812 · doc4.xml · nonDerivative · entry 1

Jones Jason C · CIK 0001775619 · VP of Product Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,142

F1 · security: Represents restricted stock units ("RSUs").

F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on August 1, 2021.

F3 · shares: 1/3 of the total number of shares of Common Stock subject to the RSUs shall vest on August 30th of each year beginning 2022.

Read SEC document
August 03, 2021 Filed Aug 5, 2021 00:38 UTC
Shaw William RChief Commercial Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-049811 · doc4.xml · nonDerivative · entry 1

Shaw William R · CIK 0001776374 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,000

F1 · security: Represents restricted stock units ("RSUs").

F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on August 1, 2021.

F3 · shares: 1/3 of the total number of shares of Common Stock subject to the RSUs shall vest on August 30th of each year beginning 2022.

Read SEC document
June 10, 2021 Filed Jun 18, 2022 00:36 UTC GrantCommon Stock 18,265 $0.00 $0.00
Disclosure

SEC source: 0001666769-22-000004 · wf-form4_165551258388396.xml · nonDerivative · entry 1

Cloyd Mary Ann · CIK 0001666769 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,175

F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · date: This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders.

Read SEC document
June 10, 2021 Filed Jun 17, 2022 20:30 UTC GrantCommon Stock 18,265 $0.00 $0.00
Disclosure

SEC source: 0001316499-22-000004 · wf-form4_165551219037780.xml · nonDerivative · entry 1

Stern Stanley · CIK 0001316499 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,500

F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · date: This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders.

Read SEC document
June 10, 2021 Filed Jun 17, 2022 20:22 UTC
SHERMAN STEVENDirector · CEO & Chairman
GrantCommon Stock 18,265 $0.00 $0.00
Disclosure

SEC source: 0001549084-22-000035 · wf-form4_165551172719268.xml · nonDerivative · entry 1

SHERMAN STEVEN · CIK 0001201619 · Director · CEO & Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 655,673

F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · date: This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders.

Read SEC document
June 10, 2021 Filed Jun 18, 2022 00:34 UTC
Li KechengDirector
GrantCommon Stock 18,265 $0.00 $0.00
Disclosure

SEC source: 0001735083-22-000004 · wf-form4_165551243039722.xml · nonDerivative · entry 1

Li Kecheng · CIK 0001735083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,408

F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · date: This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders.

Read SEC document
June 10, 2021 Filed Jun 18, 2022 00:18 UTC GrantCommon Stock 18,265 $0.00 $0.00
Disclosure

SEC source: 0001838009-22-000003 · wf-form4_165551150324187.xml · nonDerivative · entry 1

Wallen Rhonda A. · CIK 0001838009 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,175

F1 · security: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.

F2 · date: This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 16:53 UTC
Jones Jason CVP of Product Development
GrantCommon Stock 12,270 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-018271 · doc4.xml · nonDerivative · entry 1

Jones Jason C · CIK 0001775619 · VP of Product Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,142

F1 · security: Represents restricted stock units ("RSUs").

F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on March 3, 2021.

F3 · shares: The grant consists of RSUs that vest annually over three years.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:41 UTC
GLENN JOHNChief Financial Officer
GrantCommon Stock 13,015 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-018246 · doc4.xml · nonDerivative · entry 1

GLENN JOHN · CIK 0001253497 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,996

F1 · security: Represents restricted stock units ("RSUs").

F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on March 3, 2021.

F3 · shares: The grant consists of RSUs that vest annually over three years.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:49 UTC
Shaw William RChief Commercial Officer
GrantCommon Stock 16,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-018264 · doc4.xml · nonDerivative · entry 1

Shaw William R · CIK 0001776374 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,000

F1 · security: Represents restricted stock units ("RSUs").

F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on March 3, 2021.

F3 · shares: The grant consists of RSUs that vest annually over three years.

Read SEC document
March 03, 2021 Filed Mar 5, 2021 21:37 UTC
Peurach JackDirector · Chief Executive Officer
GrantCommon Stock 45,725 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-018237 · doc4.xml · nonDerivative · entry 1

Peurach Jack · CIK 0001640206 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,267

F1 · security: Represents restricted stock units ("RSUs").

F2 · date: The grant of RSUs was approved by the compensation committee of the board of directors on March 3, 2021.

F3 · shares: The grant consists of RSUs that vest annually over three years.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:36 UTC GrantCommon Stock 4,910 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-012717 · doc4.xml · nonDerivative · entry 1

Cloyd Mary Ann · CIK 0001666769 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,910

F1 · price: The grant consists of RSUs that fully vest on December 29, 2021.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:35 UTC GrantCommon Stock 4,910 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-012715 · doc4.xml · nonDerivative · entry 1

Wallen Rhonda A. · CIK 0001838009 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,910

F1 · price: The grant consists of RSUs that fully vest on December 29, 2021.

Read SEC document
January 28, 2021 Filed Jun 15, 2023 21:59 UTC
Jones Jason CChief Operating Officer
GrantCommon Stock 1,145 $0.00 $0.00
Disclosure

SEC source: 0001549084-23-000045 · wk-form4_1686880789.xml · nonDerivative · entry 3

Jones Jason C · CIK 0001775619 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By 401K

Disclosed balance after: 1,145

Read SEC document
November 10, 2020 Filed Nov 12, 2020 16:07 UTC OtherCommon Stock 744,572 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-20-057907 · doc4.xml · nonDerivative · entry 1

Wang Theodore T · CIK 0001694061 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Puissance Cross-Border Opportunities II LLC

Disclosed balance after: 29,828

F1 · kind: Puissance Cross-Border Opportunities II LLC made an in-kind distribution of an aggregate 744,572 shares of the Issuer's common stock to one of its limited partners in connection with the redemption of partnership interests.

F1 · price: Puissance Cross-Border Opportunities II LLC made an in-kind distribution of an aggregate 744,572 shares of the Issuer's common stock to one of its limited partners in connection with the redemption of partnership interests.

F2 · ownership.direct: These securities are held directly by Puissance Cross-Border Opportunities II LLC and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Cross Border Opportunities II LLC; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Cross Border Opportunities II LLC; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
July 23, 2020 Filed Jul 27, 2020 16:29 UTC GrantCommon Stock 7,383 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-043727 · doc4.xml · nonDerivative · entry 1

SCHRECK THOMAS A · CIK 0001134622 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,698

F1 · price: The grant consists of RSUs that fully vest one year from the date of grant, or July 23, 2021.

F2 · balance_after: After taking into account the 1-for-15 reverse stock split effective March 24, 2020.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.